Clinical research for HCQ
Emerging clinical trials in COVID-19: HCQ
This post comes as a part of the series of developments which are influencing the HCQ clinical trial market.
Aggressive efforts of the developed and developing countries which are focused on new drug and vaccine research focused Clinical trials for Corona virus. Nearly 1000 multi centric trials for corona virus are currently in progress as per the data availability on the Clinicaltrials.gov.in.
Some of the clinical trials focus on both existing drugs like HCQ + Azithromycin as well as at least 10 new molecules.
A brief snapshot clinical trials on Coronavirus:
| Emerging clinical trials in COVID-19: HCQ | |
| Pneumonia, respiratory failure lung injury, respiratory distress, COPD, detection, oxygen deficiency feature as key conditions | |
| Intervention Type | % |
| Behavioral | 3 |
| Biological | 9 |
| Combination Product | 1 |
| Device | 6 |
| Diagnostic Test | 8 |
| Dietary Supplement | 1 |
| Drug | 49 |
| Other & Procedure | 24 |
| HCQ as % of total trials | 7 |
| HCQ as % of Drug trials | 14 |
To know more about insights on the future impact on Coronavirus outbreak on the new drug research in viral
Disease and immunological diseases and how the same would drive treatments, log on to Rashmipant.com for Customised Research-based Report Development Services
Advantages of Customized Research-based Reports
- Helps management in making informed business decisions backed by research, improving ROI from business ventures
- Improves understanding about consumer expectations, market demand and revenue-generating strategies in pharmaceutical and clinical research domain
- Develops clear vision that helps in avoiding potential business risks due to lack of basic research